VYNE Therapeutics
NasdaqCM:VYNE
$ 0,64
$0,00 (0,00%)
0,64 $
$0,00 (0,00%)
End-of-day quote: 04/29/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

$-0,63
Earnings Per Share
$0,02
Revenue Per Share
0,00%
Operating Margin %
$0,02 B
Market Cap
$0,03 B
Long-Term Debt
Earnings Per Share
$-0,63
Revenue Per Share
$0,02
Operating Margin %
0,00%
Market Cap
$0,02 B
Long-Term Debt
$0,03 B

Financials

Year Year 2025 2024 2023 2021 2020
EPS Earnings Per Share $-0,63 $-2,45 $-2,45 $-22,68 $-53,46
Earnings Earnings $-20,99M $-37,26M $-34,55M $-70,76M $-1,52B
RPS Revenue Per Share $0,02 $0,03 $0,03 $4,73 $0,74
Revenue Revenue $0,57M $0,50M $0,42M $14,76M $20,99M
OCF Operating Cash Flow $0,00M $-33,97M $0,00M $-56,37M $-137,08M
FCF Free Cash Flow $-44,40M $0,00M $0,00M $-56,37M $-137,20M
OM Operating Margin 0,00% 0,00% 0,00% 0,00% 0,00%
GM % Gross Margin % 100,00% 100,00% 100,00% 77,31% 93,37%
FCFS Free Cash Flow Per Share $-0,77 $-0,80 $-2,47 $-1,10 $-4,23
LT Debt Long-Term Debt N/A N/A N/A N/A $33,17M
Sha. Stocks 33,32M 15,21M 14,1M 3,12M 28,5M
×